The fact
This tool represents a major breakthrough in early diagnosis and improving patient care pathways.
This acquisition strengthens Biogen's position in innovative rare genetic disease treatment.
Click the link to read an article on the topic:
This tool represents a major breakthrough in early diagnosis and improving patient care pathways.
This acquisition strengthens Biogen's position in innovative rare genetic disease treatment.